Prevalence of metabolic syndrome in patients with schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics--results from a German observational study

January 2011
BMC Psychiatry;2011, Vol. 11 Issue 1, p173
Academic Journal
The article focuses on an observational study, which explores the prevalence of metabolic syndrome (MetS) in adult in- and outpatients with untreated or treated schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics. The background, methods, results, and conclusions of the study, are discussed.


Related Articles

  • Self-perception of quality of life in patients treated with antipsychotics. DIMA, Lorena; VASILE, Daniel; ROGOZEA, Liliana; ZIA-UL-HAQ, Muhammad; BUKHARI, Shazia Anwer; MOGA, Marius // Turkish Journal of Medical Sciences;2015, Vol. 45 Issue 4, p782 

    Background/aim: Despite extensive research, normal functionality remains problematic in patients with schizophrenia. Issues such as quality of life, subjective well-being, or psychosocial performance are currently objectives of interest. There are limited data collected prospectively on...

  • The metabolic syndrome and schizophrenia: A comorbidity or an association? khalil, Rami Bou // Journal of Pharmacology & Pharmacotherapeutics;Jul-Sep2013, Vol. 4 Issue 3, p190 

    The article discusses the connection between the metabolic syndrome and schizophrenia. It states that the lifestyle of patients with schizophrenia is accompanied with the risk factors which may increase the risk of the development of metabolic syndrome. It also mentions that the risk of...

  • Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results.  // BMC Psychiatry;2011, Vol. 11 Issue 1, p167 

    The article focuses on a study, which aims to assess the effectiveness outcomes in a real-world setting in schizophrenics initiating risperidone long-acting therapy (RLAT). The study was a 24-month, multicenter, prospective, longitudinal, observational study. It is concluded that improvements...

  • Reasons and clinical outcomes of antipsychotic treatment switch in outpatients with schizophrenia in real-life clinical settings: the ETOS observational study. Roussidis, Andreas; Kalkavoura, Christina; Dimelis, Dimos; Theodorou, Afroditi; Ioannidou, Ina; Mellos, Eleytherios; Mylonaki, Triantafyllia; Spyropoulou, Areti; Yfantis, Andreas // Annals of General Psychiatry;2013, Vol. 12 Issue 1, p42 

    Background Patients under antipsychotic treatment for schizophrenia commonly exhibit poor adherence to treatment, high rates of treatment discontinuation, and frequent treatment changes. The ETOS study aimed to identify the reasons leading physicians to decide to switch antipsychotic treatment...

  • EEG alterations during treatment with olanzapine. Degner, Detlef; Nitsche, Michael; Bias, Frank; Rüther, Eckart; Reulbach, Udo // European Archives of Psychiatry & Clinical Neuroscience;Oct2011, Vol. 261 Issue 7, p483 

    The aim of this naturalistic observational study was to investigate EEG alterations in patients under olanzapine treatment with a special regard to olanzapine dose and plasma concentration. Twenty-two in-patients of a psychiatric university ward with the monodiagnosis of paranoid schizophrenia...

  • Anthropometric parameters as indicators of metabolic derangements in schizophrenia patients stabilized on olanzapine in an Indian rural population. Kumar Rout, Jayanta; Dasgupta, Anindya; Singh, Om Prakash; Banerjee, Ushasi; Das, Brahmarshi // Journal of Neurosciences in Rural Practice;Sep-Dec2012, Vol. 3 Issue 3, p277 

    Context: For any given body mass, Asian Indians have higher central obesity than Europeans. A periodic measurement of body mass index (BMI) and waist hip ratio (WHR) is practically more feasible than other parameters of metabolic syndrome by repeated blood collection. However, few studies are...

  • The effect of antipsychotic medication on metabolic syndrome. Jones, Martin // Nursing Standard;8/6/2008, Vol. 22 Issue 48, p43 

    This article highlights the need for mental health nurses to take a proactive role in the identification and prevention of metabolic syndrome to improve quality of life for patients with schizophrenia, A range of strategies to help mental health nurses address some of the physical health...

  • Effects of second-generation antipsychotics on selected markers of one-carbon metabolism and metabolic syndrome components in first-episode schizophrenia patients. Misiak, Błażej; Frydecka, Dorota; Łaczmański, Łukasz; Ślęzak, Ryszard; Kiejna, Andrzej // European Journal of Clinical Pharmacology;Dec2014, Vol. 70 Issue 12, p1433 

    Purpose: Alterations in one-carbon metabolism (OCM) have been repeatedly reported in schizophrenia. However, there is a scarcity of studies addressing the effects of antipsychotics on selected OCM markers in schizophrenia and provided results are inconsistent. Methods: We recruited 39...

  • DURATION OF ILLNESS, SYMPTOMS AND FUNCTIONAL RECOVERY IN PATIENTS SUFFERING FROM SCHIZOPHRENIA. Nazar, Zahid; Rabbani, Fazle; Ali, Gohar; Zahoor, Nazish; Lawangeen, Sibtain; Awan, Naila Riaz // Journal of Pakistan Psychiatric Society;Jul-Dec2013, Vol. 10 Issue 2, p77 

    Objective: To assess the symptomatic and functional recovery with long duration of illness of schizophrenics at baseline and after at 5 years follow up Design: Descriptive observational study. Place and Duration of study: This study was conducted at department of Psychiatry Lady Reading Hospital...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics